1. Exploiting Human Memory B Cell Heterogeneity for Improved Vaccine Efficacy
- Author
-
Noel Thomas Pauli, Carole J. Henry Dunand, and Patrick C. Wilson
- Subjects
lcsh:Immunologic diseases. Allergy ,memory B cell ,Immunology ,Review Article ,Affinity maturation ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,antibody ,vaccine ,medicine ,Immunology and Allergy ,Compartment (development) ,Memory B cell ,B cell ,030304 developmental biology ,0303 health sciences ,biology ,business.industry ,anthrax ,Vaccine efficacy ,3. Good health ,Vaccination ,medicine.anatomical_structure ,biology.protein ,Antibody ,business ,lcsh:RC581-607 ,influenza ,immunoglobulin ,B cell subset ,030215 immunology - Abstract
The major goal in vaccination is establishment of long-term, prophylactic humoral memory to a pathogen. Two major components to long-lived humoral memory are plasma cells for the production of specific immunoglobulin and memory B cells that survey for their specific antigen in the periphery for later affinity maturation, proliferation, and differentiation. The study of human B cell memory has been aided by the discovery of a general marker for B cell memory, expression of CD27; however, new data suggests the existence of CD27- memory B cells as well. These recently described non-canonical memory populations have increasingly pointed to the heterogeneity of the memory compartment. The novel B memory subsets in humans appear to have unique origins, localization, and functions compared to what was considered to be a classical memory B cell. In this article, we review the known B cell memory subsets, the establishment of B cell memory in vaccination and infection, and how understanding these newly described subsets can inform vaccine design and disease treatment.
- Published
- 2011
- Full Text
- View/download PDF